Randomised, Double-blind, Comparative Clinical Study of New Ranibizumab Biosimilar in Neovascular (Wet) Age-Related Macular Degeneration

Overview of attention for article published in Clinical Ophthalmology, July 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 2 X users

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 4 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 3,331 followers.

New ranibizumab biosimilar in macular degeneration | OPTH @DovePress https://t.co/pjLrwVTLBY

Reply Repost Favourite

Ophthopedia Update: Randomised, Double-blind, Comparative Clinical Study of New Ranibizumab Biosimilar in Neovascular (Wet) Age-Related Macular Degeneration https://t.co/FWCoNUezlE #Ophthomology #Eye #Ophthotwitter

Reply Repost Favourite